ImmunoGen, Inc. – LSE:0A8K.L
ImmunoGen stock price today
ImmunoGen stock price monthly change
ImmunoGen stock price quarterly change
ImmunoGen key metrics
Market Cap | 8.26B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.30 |
Revenue | 287.61M |
EBITDA | -68.63M |
Income | -73.07M |
Revenue Q/Q | 637.72% |
Revenue Y/Y | 200.82% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -23.86% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeImmunoGen stock price history
ImmunoGen stock forecast
ImmunoGen financial statements
| Dec 2022 | 41.16M | -59.00M | -143.34% |
|---|---|---|---|
| Mar 2023 | 49.86M | -40.56M | -81.35% |
| Jun 2023 | 83.15M | -4.24M | -5.11% |
| Sep 2023 | 113.42M | 30.74M | 27.11% |
| Dec 2022 | 348936000 | 193.11M | 55.34% |
|---|---|---|---|
| Mar 2023 | 288345000 | 166.42M | 57.72% |
| Jun 2023 | 714327000 | 223.48M | 31.29% |
| Sep 2023 | 822101000 | 260.50M | 31.69% |
| Dec 2022 | -60.19M | -248K | 26.07M |
|---|---|---|---|
| Mar 2023 | -73.71M | -209K | 39K |
| Jun 2023 | -66.74M | -78K | 437.55M |
| Sep 2023 | 2.77M | -1.35M | 32.13M |
ImmunoGen alternative data
| Aug 2023 | 277 |
|---|---|
| Sep 2023 | 277 |
| Oct 2023 | 277 |
| Nov 2023 | 277 |
| Dec 2023 | 277 |
| Jan 2024 | 277 |
| Feb 2024 | 277 |
| Mar 2024 | 277 |
| Apr 2024 | 277 |
| May 2024 | 277 |
| Jun 2024 | 277 |
| Jul 2024 | 277 |
ImmunoGen other data
-
What's the price of ImmunoGen stock today?
One share of ImmunoGen stock can currently be purchased for approximately $3.8.
-
When is ImmunoGen's next earnings date?
Unfortunately, ImmunoGen's (0A8K.L) next earnings date is currently unknown.
-
Does ImmunoGen pay dividends?
No, ImmunoGen does not pay dividends.
-
How much money does ImmunoGen make?
ImmunoGen has a market capitalization of 8.26B.
-
What is ImmunoGen's stock symbol?
ImmunoGen, Inc. is traded on the LSE under the ticker symbol "0A8K.L".
-
What is ImmunoGen's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ImmunoGen?
Shares of ImmunoGen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does ImmunoGen have?
As Jul 2024, ImmunoGen employs 277 workers.
-
When ImmunoGen went public?
ImmunoGen, Inc. is publicly traded company for more then 4 years since IPO on 14 Apr 2021.
-
What is ImmunoGen's official website?
The official website for ImmunoGen is immunogen.com.
-
Where are ImmunoGen's headquarters?
ImmunoGen is headquartered at 830 Winter Street, Waltham, MA.
-
How can i contact ImmunoGen?
ImmunoGen's mailing address is 830 Winter Street, Waltham, MA and company can be reached via phone at +7 818950600.
ImmunoGen company profile:
ImmunoGen, Inc.
immunogen.comLSE
277
Biotechnology
Healthcare
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
Waltham, MA 02451-1477
:
ISIN: US45253H1014
:
